Abstract
Gestational trophoblastic disease (GTD) is a spectrum of premalignant and malignant tumors that develop from placental tissue and thus are associated with pregnancy. Outcomes for GTD have significantly improved over the last few decades with overall cure rates now well over 90%. Chemotherapy is essential to the treatment of GTN and a key factor in the improved cure rates. Although surgery is not as frequently indicated or utilized in the management of GTD, there are key instances in which surgery plays an important role in improving patient outcomes. These instances include primary uterine evacuation of hydatidiform moles, primary hysterectomy for molar pregnancies and malignant GTN, secondary hysterectomy and/or other excisional procedures for chemotherapy-resistant disease, excisional procedures to improve chemotherapy response, and surgical management of disease complications. In this chapter, we will review in detail the indications for surgery in the management of GTD.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abu-Rustum NR, et al. Gestational trophoblastic neoplasia, version 2.2019, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw. 2019;17(11):1374–91.
Berek JS, Hacker NF. Berek & Hacker's gynecologic oncology. 6th ed. Philadelphia: Wolters Kluwer; 2015. p. xvi. 960 pages
Lurain JR. Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole. Am J Obstet Gynecol. 2010;203(6):531–9.
Ngan HYS, et al. Update on the diagnosis and management of gestational trophoblastic disease. Int J Gynaecol Obstet. 2018;143(Suppl 2):79–85.
Brown J, et al. 15 years of progress in gestational trophoblastic disease: scoring, standardization, and salvage. Gynecol Oncol. 2017;144(1):200–7.
Doll KM, Soper JT. The role of surgery in the management of gestational trophoblastic neoplasia. Obstet Gynecol Surv. 2013;68(7):533–42.
Lurain JR. Gestational trophoblastic disease II: classification and management of gestational trophoblastic neoplasia. Am J Obstet Gynecol. 2011;204(1):11–8.
Soper JT. Gestational trophoblastic neoplasia. Curr Opin Obstet Gynecol. 1990;2(1):92–7.
Berkowitz RS, Goldstein DP. Clinical practice. Molar pregnancy. N Engl J Med. 2009;360(16):1639–45.
Mungan T, et al. Hydatidiform mole: clinical analysis of 310 patients. Int J Gynaecol Obstet. 1996;52(3):233–6.
Tidy JA, et al. Gestational trophoblastic disease: a study of mode of evacuation and subsequent need for treatment with chemotherapy. Gynecol Oncol. 2000;78(3 Pt 1):309–12.
Curry SL, et al. Hydatidiform mole: diagnosis, management, and long-term followup of 347 patients. Obstet Gynecol. 1975;45(1):1–8.
Montz FJ, Schlaerth JB, Morrow CP. The natural history of theca lutein cysts. Obstet Gynecol. 1988;72(2):247–51.
Zhao P, Chen Q, Lu W. Comparison of different therapeutic strategies for complete hydatidiform mole in women at least 40 years old: a retrospective cohort study. BMC Cancer. 2017;17(1):733.
Elias KM, Goldstein DP, Berkowitz RS. Complete hydatidiform mole in women older than age 50. J Reprod Med. 2010;55(5–6):208–12.
Elias KM, et al. Complete hydatidiform mole in women aged 40 to 49 years. J Reprod Med. 2012;57(5–6):254–8.
Osborne RJ, et al. Second curettage for low-risk nonmetastatic gestational trophoblastic neoplasia. Obstet Gynecol. 2016;128(3):535–42.
Pezeshki M, et al. The role of repeat uterine evacuation in the management of persistent gestational trophoblastic disease. Gynecol Oncol. 2004;95(3):423–9.
Eysbouts YK, et al. The added value of hysterectomy in the management of gestational trophoblastic neoplasia. Gynecol Oncol. 2017;145(3):536–42.
Hammond CB, Weed JC Jr, Currie JL. The role of operation in the current therapy of gestational trophoblastic disease. Am J Obstet Gynecol. 1980;136(7):844–58.
Suzuka K, et al. Adjuvant hysterectomy in low-risk gestational trophoblastic disease. Obstet Gynecol. 2001;97(3):431–4.
Doumplis D, et al. A review of the management by hysterectomy of 25 cases of gestational trophoblastic tumours from March 1993 to January 2006. BJOG. 2007;114(9):1168–71.
Fang J, et al. Role of adjuvant hysterectomy in management of high-risk gestational trophoblastic neoplasia. Int J Gynecol Cancer. 2012;22(3):509–14.
Mutch DG, et al. Recurrent gestational trophoblastic disease. Experience of the Southeastern Regional Trophoblastic Disease Center. Cancer. 1990;66(5):978–82.
Gadducci A, et al. Placental site trophoblastic tumor and epithelioid trophoblastic tumor: clinical and pathological features, prognostic variables and treatment strategy. Gynecol Oncol. 2019;153(3):684–93.
Papadopoulos AJ, et al. Twenty-five years’ clinical experience with placental site trophoblastic tumors. J Reprod Med. 2002;47(6):460–4.
Sobecki-Rausch J, et al. Surgery and platinum/etoposide-based chemotherapy for the treatment of epithelioid trophoblastic tumor. Int J Gynecol Cancer. 2018;28(6):1117–22.
Lang JF, Childers JM, Surwit EA. Laparoscopic hysterectomy for persistent gestational trophoblastic neoplasia. J Am Assoc Gynecol Laparosc. 1995;2(4):475–7.
Berkowitz BJ, et al. Ovarian conservation in placental site trophoblastic tumor. Gynecol Oncol. 1990;37(2):239–43.
Case AM, et al. Fertility-sparing surgery, with subsequent pregnancy, in persistent gestational trophoblastic neoplasia: case report. Hum Reprod. 2001;16(2):360–4.
Kanazawa K, et al. Clinical evaluation of focal excision of myometrial lesion for treatment of invasive hydatidiform mole. Acta Obstet Gynecol Scand. 1988;67(6):487–92.
Pfeffer PE, et al. Fertility-sparing partial hysterectomy for placental-site trophoblastic tumour. Lancet Oncol. 2007;8(8):744–6.
Saso S, et al. Placental site trophoblastic tumours and the concept of fertility preservation. BJOG. 2012;119(3):369–74. discussion 374
Chiofalo B, et al. Fertility sparing strategies in patients affected by placental site trophoblastic tumor. Curr Treat Options in Oncol. 2017;18(10):58.
Kanis MJ, Lurain JR. Pulmonary resection in the management of high-risk gestational trophoblastic neoplasia. Int J Gynecol Cancer. 2016;26(4):796–800.
Tomoda Y, et al. Surgical indications for resection in pulmonary metastasis of choriocarcinoma. Cancer. 1980;46(12):2723–30.
Jr. Evans AC, et al. Gestational trophoblastic disease metastatic to the central nervous system. Gynecol Oncol. 1995;59(2):226–30.
Ishizuka T, et al. Intracranial metastasis of choriocarcinoma. A clinicopathologic study. Cancer. 1983;52(10):1896–903.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Guntupalli, S.R., Moroney, M.R. (2021). Surgical Management of Gestational Trophoblastic Disease. In: Nayak, B., Singh, U. (eds) Gestational Trophoblastic Disease. Springer, Singapore. https://doi.org/10.1007/978-981-33-4878-3_12
Download citation
DOI: https://doi.org/10.1007/978-981-33-4878-3_12
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-33-4877-6
Online ISBN: 978-981-33-4878-3
eBook Packages: MedicineMedicine (R0)